ReviewInternational journal of molecular sciences2021

Current Immunotherapeutic Strategies Targeting the PD-1/PD-L1 Axis in Non-Small Cell Lung Cancer with Oncogenic Driver Mutations.

Ichidai Tanaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.